Author

W.-S. Choi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

B. Kim· 1 shared D. H. Kang· 1 shared E.-G. Kim· 1 shared J. H. Jeong· 1 shared J.-H. Choi· 1 shared J.-Y. Lee· 1 shared M.-S. Song· 1 shared O.-J. Lee· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Kim

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice

J. H. Jeong, S. Chokkakula, S. C. Min, B. Kim, W.-S. Choi, S. Oh, Y. S. Yun, D. H. Kang, O.-J. Lee, E.-G. Kim, J.-H. Choi, J.-Y. Lee, Y. K. Choi, Y. H. Baek, M.-S. Song

This paper evaluates combination antiviral therapies in SARS-CoV-2 infected mice, finding that nirmatrelvir and molnupiravir together significantly improve survival compared to monotherapies.

bioRxiv · Jun 27, 2022Microbiology